Adenoid Cystic Carcinoma, Solid-Basaloid Subtype of the Breast: A Case Report.
Yuki HaraRin YamaguchiHiroshi YanoKeisuke IwasakiPublished in: International journal of surgical pathology (2022)
We present a rare tumor of adenoid cystic carcinoma, solid-basaloid subtype of the breast. Solid-basaloid adenoid cystic carcinoma may have a worse prognosis than classical adenoid cystic carcinoma. A 70-year-old woman presented with a mass in her left breast. Malignancy was suspected on imaging and confirmed via core needle biopsy. Left breast partial mastectomy and sentinel lymph node biopsy were performed. Histologically, the tumor was composed of basaloid cells with hyperchromatic nuclei and frequent mitotic figures, as are small-cell neuroendocrine carcinomas. Immunohistochemical analysis of the tumor cells showed high expression of KIT and CD10 and focal expression of keratin 7. Synaptophysin, chromogranin A, estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 were not expressed. This patient should be followed up carefully for distant metastases and recurrences.
Keyphrases
- estrogen receptor
- epidermal growth factor receptor
- sentinel lymph node
- poor prognosis
- ultrasound guided
- lymph node
- endothelial cells
- tyrosine kinase
- induced apoptosis
- high resolution
- early stage
- neoadjuvant chemotherapy
- fine needle aspiration
- single cell
- pulmonary embolism
- cell therapy
- squamous cell carcinoma
- cell death
- signaling pathway
- mesenchymal stem cells
- mass spectrometry
- free survival